0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Seres Therapeutics Inc - Trending symbols

Notifications

TypeNotificationDate
RSI OversoldOversold RSI (Relative Strength Index)2025-04-17



Trends

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Total Other Income Expense Net -1,722-1,243-2,9651,440-1,525-20,340-21,86535,06313,198
Net Working Capital 76,751-10,04866,703-25,72040,983-32,8888,095-10,643-2,548
Total Stockholder Equity -15,123-29,733-44,856-14,882-59,738-27,336-87,074110,99323,919
Net Income -47,8546,606-41,2481,115-40,1337,263-32,870121,64688,776
Net Interest Income -1,440-618-2,058-957-3,015798-2,2172,869652
Income before Tax -47,8546,606-41,2481,115-40,1337,263-32,870121,64688,776
EBIT -63,3254,218-59,107-9,200-68,307-2,261-70,568118,78048,212
EBITDA -61,5495,021-56,528-8,761-65,289-2,537-67,826117,56549,739
Operating Income -63,3254,218-59,107-9,200-68,307-2,261-70,568120,09249,524
Net Income from Continuing Operations -64,7354,733-60,002-8,794-68,796-2,378-71,174117,72646,552
Net Debt -75,56025,942-49,618-79,740-129,358128,918-44068,30967,869
Net Tangible Assets 80,956-57,89823,05844,52767,585-56,80210,783-58,654-47,871
Accumulated Other Comprehensive Income -215-41-256138-118106-12142
Total Revenue 1,493-2771,2162,2283,444-2,469975-1,497-522
Gross Profit 7,221-5,7281,493-5489451,4482,393-2,422-29
Other Stockholders Equity 727,8695,664733,5336,455739,9885,841745,829-746,044-215
Other Operating Expenses 35,4625,58241,04412,36153,4054,91358,318-58,923-605
Interest Expense 759-636963673212744-5,826-5,082

Comments

How you think about this?

Leave a comment

Stay informed about Seres Therapeutics Inc.

Receive notifications about Seres Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.